Diagnostics & Imaging
Heartvue.Proton
AI platform that automates cardiac MRI measurements, volumetric quantification and blood flow analysis under physician review.
The Signal
FDA 510(k) cleared in August 2026 (K260811) on the company's first submission, with an authorized Predetermined Change Control Plan that lets its models improve without new submissions.
More in Diagnostics & Imaging
Aidoc
AI-driven triage and notification software for detecting acute abnormalities in medical imaging scans.
View toolViz.ai
Care coordination platform using artificial intelligence to identify strokes and other vascular diseases.
View toolLunit INSIGHT
AI-powered radiology solutions for detecting lung abnormalities and breast cancer on chest X-rays.
View toolPaige AI
FDA-cleared digital pathology software utilizing artificial intelligence to assist pathologists in cancer detection.
View tooliRhythm Zio
Ambulatory cardiac monitoring service using wearable biosensors and cloud-based data analytics.
View toolPathAI
AI-powered pathology analysis tools for drug development and diagnostic accuracy in clinical trials.
View tool